Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""HIV"" wg kryterium: Temat


Tytuł :
Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy.
Autorzy :
Shekatkar M; Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India.
Kheur S; Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India.
Gupta AA; Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India.
Arora A; Dr. D. Y. Patil Dental College, and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India.
Raj AT; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Patil S; Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Kingdom of Saudi Arabia. Electronic address: .
Khan SS; Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Kingdom of Saudi Arabia.
Desai A; Department of Oral Pathology and Microbiology, People's College of Dental Sciences and Research Centre, People's University; Bhopal, India.
Carroll WB; College of Dental Medicine, Roseman University of Health Sciences, South Jordan, Utah, USA.
Awan KH; College of Dental Medicine, Roseman University of Health Sciences, South Jordan, Utah, USA. Electronic address: .
Pokaż więcej
Źródło :
Disease-a-month : DM [Dis Mon] 2021 Sep; Vol. 67 (9), pp. 101169. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiretroviral Therapy, Highly Active*
Candidiasis, Oral*/etiology
Candidiasis, Oral*/prevention & control
HIV Infections*/complications
HIV Infections*/drug therapy
Anti-HIV Agents/*therapeutic use
AIDS-Related Opportunistic Infections/microbiology ; Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/drug therapy ; Acquired Immunodeficiency Syndrome/virology ; HIV ; Humans ; Mouth/drug effects ; Mouth/microbiology
Czasopismo naukowe
Tytuł :
Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
Autorzy :
Machowski EE; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research (CBTBR), University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa. .
Letutu M; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Lebina L; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Waja Z; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Msandiwa R; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Milovanovic M; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Gordhan BG; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research (CBTBR), University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa.
Otwombe K; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Friedrich SO; TASK Applied Science, Bellville, Cape Town, South Africa and Pulmonology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Chaisson R; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Diacon AH; TASK Applied Science, Bellville, Cape Town, South Africa and Pulmonology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Kana B; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research (CBTBR), University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa.
Martinson N; Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research (CBTBR), University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa.; Perinatal HIV Research Unit (PHRU), SAMRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 May 22; Vol. 21 (1), pp. 466. Date of Electronic Publication: 2021 May 22.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
AIDS-Related Opportunistic Infections*/drug therapy
AIDS-Related Opportunistic Infections*/virology
HIV Seropositivity*/drug therapy
HIV Seropositivity*/virology
Antitubercular Agents/*therapeutic use
Bacterial Load/*drug effects
HIV/*immunology
Mycobacterium tuberculosis/*genetics
Mycobacterium tuberculosis/*isolation & purification
Sputum/*microbiology
Tuberculosis, Pulmonary/*drug therapy
Adult ; Anti-HIV Agents/therapeutic use ; Diagnostic Tests, Routine ; Female ; Follow-Up Studies ; Humans ; Male ; Microscopy ; Nucleic Acid Amplification Techniques ; Prospective Studies ; Treatment Outcome ; Tuberculosis, Pulmonary/virology
Czasopismo naukowe
Tytuł :
SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts.
Autorzy :
Kamya MR; Makerere University, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.
Petersen ML; University of California Berkeley, Berkeley, California, USA.
Kabami J; Infectious Diseases Research Collaboration, Kampala, Uganda.
Ayieko J; KEMRI-UCSF, Kisumu, Kenya.
Kwariisima D; Infectious Diseases Research Collaboration, Kampala, Uganda.
Sang N; KEMRI-UCSF, Kisumu, Kenya.
Clark TD; University of California San Francisco, San Francisco, California, USA.
Schwab J; University of California Berkeley, Berkeley, California, USA.
Charlebois ED; University of California San Francisco, San Francisco, California, USA.
Cohen CR; University of California San Francisco, San Francisco, California, USA.
Bukusi EA; KEMRI-UCSF, Kisumu, Kenya.
Peng J; University of California San Francisco, San Francisco, California, USA.
Jain V; University of California San Francisco, San Francisco, California, USA.
Chen YH; University of California San Francisco, San Francisco, California, USA.
Chamie G; University of California San Francisco, San Francisco, California, USA.
Balzer LB; University of Massachusetts Amherst, Amherst, Massachusetts, USA.
Havlir DV; University of California San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1938-e1945.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Adult ; CD4 Lymphocyte Count ; Female ; HIV ; Humans ; Male ; Uganda/epidemiology
Czasopismo naukowe
Tytuł :
Prescribing intranasal steroids in HIV-positive patients: systematic review of the literature.
Autorzy :
Seymour N; Department of ENT, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Robinson M; Department of ENT, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Richardson D; Department of HIV Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Mohammed H; Department of HIV Medicine, Chelsea and Westminster NHS Foundation Trust, London, UK.
Williams D; Department of HIV Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
McGilligan JA; Department of ENT, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Pokaż więcej
Źródło :
The Journal of laryngology and otology [J Laryngol Otol] 2021 Sep; Vol. 135 (9), pp. 755-758. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
HIV*
Adrenal Cortex Hormones/*adverse effects
Cushing Syndrome/*chemically induced
HIV Infections/*drug therapy
HIV Protease Inhibitors/*adverse effects
Administration, Intranasal ; Adrenal Cortex Hormones/administration & dosage ; Adult ; Cobicistat/administration & dosage ; Cobicistat/adverse effects ; Drug Interactions ; Fluticasone/administration & dosage ; Fluticasone/adverse effects ; HIV Protease Inhibitors/administration & dosage ; Humans ; Male ; Ritonavir/administration & dosage ; Ritonavir/adverse effects
Czasopismo naukowe
Tytuł :
Trends in Comorbidities Among Human Immunodeficiency Virus-Infected Hospital Admissions in New York City from 2006-2016.
Autorzy :
Rowell-Cunsolo TL; University of Wisconsin-Madison, School of Social Work, Madison, Wisconsin, USA.
Hu G; Columbia University, Mailman School of Public Health, New York, New York, USA.
Bellerose M; Columbia University, Mailman School of Public Health, New York, New York, USA.
Liu J; Columbia University School of Nursing, New York, New York, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1957-e1963.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
HIV Infections*/complications
HIV Infections*/epidemiology
Adult ; Comorbidity ; HIV ; Hospitals ; Humans ; New York City/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.
Autorzy :
Rebeiro PF; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Jenkins CA; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Bian A; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Lake JE; University of Texas Health Science Center at Houston, Houston, Texas, USA.
Bourgi K; Indiana University School of Medicine, Indianapolis, Indiana, USA.
Moore RD; Johns Hopkins University, Baltimore, Maryland, USA.
Horberg MA; Mid-Atlantic Permanente Research Institute, Rockville, Maryland, USA.
Matthews WC; University of California, San Diego, San Diego, California, USA.
Silverberg MJ; Kaiser Permanente Northern California, Oakland, California, USA.
Thorne J; Johns Hopkins University, Baltimore, Maryland, USA.
Mayor AM; Retrovirus Research Center, Universidad Central del Caribe, Bayamón, Puerto Rico, USA.
Lima VD; University of British Columbia, Vancouver, British Columbia, Canada.
Palella FJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Saag MS; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Althoff KN; Johns Hopkins University, Baltimore, Maryland, USA.
Gill MJ; University of Calgary, Calgary, Alberta, Canada.
Wong C; Johns Hopkins University, Baltimore, Maryland, USA.
Klein MB; McGill University, Montreal, Quebec, Canada.
Crane HM; University of Washington, Seattle, Washington, USA.
Marconi VC; Emory University School of Medicine, Atlanta, Georgia, USA.
Shepherd BE; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Sterling TR; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Koethe JR; Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e2234-e2242.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Anti-HIV Agents*/therapeutic use
Diabetes Mellitus*/drug therapy
Diabetes Mellitus*/epidemiology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Integrase Inhibitors*/therapeutic use
Adult ; Canada ; HIV ; Humans ; Reverse Transcriptase Inhibitors/adverse effects ; United States/epidemiology ; Viral Load ; Weight Gain
Czasopismo naukowe
Tytuł :
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.
Autorzy :
Greenberg L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
Ryom L; Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Neesgaard B; Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Staub T; Infectious Diseases, Centre Hospitalier Luxembourg (CHL), Luxembourg City, Luxembourg.
Gisinger M; Medizinische Universität Innsbruck , Innsbruck, Austria.
Skoll M; Wiener Medizinische Universität, Vienna, Austria.
Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Scherrer A; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Mussini C; Modena HIV Cohort, Università degli Studi di Modena , Modena, Italy.
Smith C; Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom.
Johnson M; Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, United Kingdom.
De Wit S; Saint Pierre University Hospital, Université Libre de Bruxelles , Brussels, Belgium.
Necsoi C; Saint Pierre University Hospital, Université Libre de Bruxelles , Brussels, Belgium.
Pradier C; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.
Wit F; AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA), Stichting HIV Monitoring (SHM), Amsterdam, The Netherlands.
Lehmann C; University Hospital Cologne, Cologne, Germany.
d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals, (ICONA) L'Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e Carlo , Milano, Italy.
Miró JM; Hospital Clinic-August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain.
Castagna A; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Spagnuolo V; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Sönnerborg A; Division of Infectious Diseases, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Law M; Australian HIV Observational Database (AHOD), University of New South Wales (UNSW) , Sydney Australia.
Hutchinson J; Australian HIV Observational Database (AHOD), University of New South Wales (UNSW) , Sydney Australia.
Chkhartishvili N; Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center , Tbilisi, Georgia.
Bolokadze N; Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center , Tbilisi, Georgia.
Wasmuth JC; University Hospital Bonn, Bonn, Germany.
Stephan C; Medical Department No. 2, Infectious Diseases Unit, Goethe-University Hospital Frankfurt, Frankfurt, Germany.
Vannappagari V; ViiV Healthcare, RTP, Research Triangle Park, North Carolina, USA.
Rogatto F; Gilead science, Foster City, California, USA.
Llibre JM; Hospital Universitari Germans Trias i Pujol Department of Internal Medicine, HIV Unit, Barcelona, Spain.
Duvivier C; Assistance Publique - Hôpitaux de Paris (APHP)-Hôpital Necker-Enfants Malades, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker-Pasteur, Institut hospitalo-universitaire (IHU) Imagine , Paris, France.
Hoy J; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Victoria, Australia.
Bloch M; Australian HIV Observational Database (AHOD), University of New South Wales (UNSW) , Sydney Australia.
Bucher HC; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
Calmy A; HIV/AIDS Unit in Geneva University Hospital, Geneva, Switzerland.
Volny Anne A; European AIDS Treatment Group, Brussels, Belgium.
Pelchen-Matthews A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
Lundgren JD; Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Peters L; Centre of Excellence for Health, Immunity and Infections (CHIP), Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Bansi-Matharu L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
Mocroft A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
Pokaż więcej
Corporate Authors :
RESPOND (International Cohort Consortium of Infectious Diseases) Study Group
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e2323-e2333.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Pharmaceutical Preparations*
Anti-Retroviral Agents/therapeutic use ; HIV ; Humans
Czasopismo naukowe
Tytuł :
Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.
Autorzy :
Collins LF; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.; Grady Healthcare System, Infectious Diseases Program, Atlanta, Georgia, USA.
Sheth AN; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.; Grady Healthcare System, Infectious Diseases Program, Atlanta, Georgia, USA.
Mehta CC; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Naggie S; Duke Clinical Research Institute and Duke University School of Medicine, Durham, North Carolina, USA.
Golub ET; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Anastos K; Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
French AL; Division of Infectious Diseases, CORE Center, Stroger Hospital of Cook County, Chicago, Illinois, USA.
Kassaye S; Georgetown University Medical Center, Washington, D.C., USA.
Taylor TN; Downstate Health Sciences University, Brooklyn, New York, USA.
Fischl MA; Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
Adimora AA; School of Medicine and Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Kempf MC; Schools of Nursing, Public Health, and Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Palella FJ; Division of Infectious Diseases, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Tien PC; Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.; Medical Service, Department of Veterans Affairs, San Francisco, California, USA.
Ofotokun I; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.; Grady Healthcare System, Infectious Diseases Program, Atlanta, Georgia, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e2059-e2069.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Acquired Immunodeficiency Syndrome*
HIV Infections*/complications
HIV Infections*/epidemiology
Adult ; Aged ; Comorbidity ; Female ; HIV ; Humans ; Risk Factors ; United States/epidemiology
Czasopismo naukowe
Tytuł :
CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018.
Autorzy :
Lee JS; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.
Humes EA; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.
Hogan BC; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.
Buchacz K; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Gill MJ; Southern Alberta HIV Clinic, Calgary, Alberta, Canada.
Sterling TR; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Rebeiro PF; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lima VD; BC Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, British Columbia, Canada.
Mayor A; Department of Medicine, Universidad Central del Caribe, Bayamon, Puerto Rico.
Silverberg MJ; Kaiser Permanente Northern California, Oakland, California, USA.
Horberg MA; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
Moore RD; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Althoff KN; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.
Pokaż więcej
Corporate Authors :
North American AIDS Cohort Collaboration on Research and Design
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e2334-e2337.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Antiretroviral Therapy, Highly Active ; CD4 Lymphocyte Count ; HIV ; Humans ; Prescriptions ; United States/epidemiology
Czasopismo naukowe
Tytuł :
The Human Immunodeficiency Virus (HIV) Index: Using a Patient-Reported Outcome on Engagement in HIV Care to Explain Suboptimal Retention in Care and Virologic Control.
Autorzy :
Christopoulos KA; Department of Medicine, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco, California, USA.
Neilands TB; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Koester KA; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Sauceda JA; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Dilworth SE; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Mugavero MJ; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Crane HM; Department of Medicine, University of Washington, Seattle, Washington, USA.
Fredericksen RJ; Department of Medicine, University of Washington, Seattle, Washington, USA.
Cachay ER; Department of Medicine, University of California, San Diego, San Diego, California, USA.
Mayer KH; The Fenway Institute at Fenway Health, Boston, Massachusetts, USA.
Moore RD; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Napravnik S; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Johnson MO; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e2175-e2183.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Retention in Care*
Cohort Studies ; HIV ; Humans ; Patient Reported Outcome Measures ; United States ; Viral Load
Czasopismo naukowe
Tytuł :
Modeling Combination Interventions to Prevent Human Immunodeficiency Virus in Adolescent Girls and Young Women in South Africa (HIV Prevention Trials Network 068).
Autorzy :
Stoner MCD; Carolina Population Center, University of North Carolina, Chapel Hill, North Carolina, USA.; Women's Global Health Imperative, RTI International, San Francisco, California, USA.
Westreich D; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ahern J; School of Public Health, Division of Epidemiology and Biostatistics, University of California, Berkeley, Berkeley, California, USA.
Edwards J; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Gómez-Olivé FX; Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Tollman SM; Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; INDEPTH Network, Accra, Ghana.
Lippman S; Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Kahn K; Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; INDEPTH Network, Accra, Ghana.; Epidemiology and Global Health Unit, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Pettifor A; Carolina Population Center, University of North Carolina, Chapel Hill, North Carolina, USA.; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Medical Research Council/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1911-e1918.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Adolescent ; Female ; HIV ; Humans ; Incidence ; Rural Population ; Sexual Behavior ; South Africa/epidemiology
Czasopismo naukowe
Tytuł :
Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.
Autorzy :
Jacobs P; National Institute on Drug Abuse, Bethesda, Maryland, USA.
Feaster DJ; University of Miami, Miami, Florida, USA.
Pan Y; University of Miami, Miami, Florida, USA.
Gooden LK; Columbia University, New York, New York, USA.
Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Lucas GM; Johns Hopkins University, Baltimore, Maryland, USA.
Jain MK; UT Southwestern Medical Center, Dallas, Texas, USA.
Marsh EL; Butler Hospital, Providence, Rhode Island, USA.
Armstrong WS; Emory University School of Medicine, Atlanta, Georgia, USA.
Rodriguez A; University of Miami, Miami, Florida, USA.
Del Rio C; Emory University School of Medicine, Atlanta, Georgia, USA.
Metsch LR; Columbia University, New York, New York, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1982-e1990.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Substance-Related Disorders*/complications
Substance-Related Disorders*/drug therapy
Substance-Related Disorders*/epidemiology
Ambulatory Care ; HIV ; Hospitals ; Humans
Czasopismo naukowe
Tytuł :
Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada.
Autorzy :
Lu H; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Cole SR; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Westreich D; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Hudgens MG; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Adimora AA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Althoff KN; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Silverberg MJ; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Buchacz K; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Li J; Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Edwards JK; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Rebeiro PF; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lima VD; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Marconi VC; Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.
Sterling TR; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Horberg MA; Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.
Gill MJ; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Kitahata MM; Department of Medicine, University of Washington, Seattle, Washington, USA.
Eron JJ; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Moore RD; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1408-e1414.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
HIV Infections*/drug therapy
HIV Integrase Inhibitors*/therapeutic use
Adult ; Canada ; Cohort Studies ; HIV ; Humans ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Barriers to HIV testing as reported by individuals newly diagnosed with HIV infection in Sweden.
Autorzy :
George-Svahn L; Rinkeby Primary Health Care Center, Stockholm, Sweden.; Dept. of Health Sciences, The Swedish Red Cross University College, Huddinge, Sweden.
Eriksson LE; Dept. of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Dept. of Learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden.; School of Health Sciences, City, University of London, London, UK.
Wiklander M; Dept. of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Björling G; Dept. of Health Sciences, The Swedish Red Cross University College, Huddinge, Sweden.; Dept. of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.; Faculty of Nursing, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Svedhem V; Dept. of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.; Div. of Infectious Disease, Dept. of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
Brännström J; Div. of Infectious Disease, Dept. of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Dept. of Infectious Diseases/Venhälsan, Stockholm South General Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2021 Oct; Vol. 33 (10), pp. 1286-1295. Date of Electronic Publication: 2020 Nov 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Cross-Sectional Studies ; HIV Testing ; Humans ; Mass Screening ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Profile of Chronic Comorbid Conditions and Obstetrical Complications Among Pregnant Women With Human Immunodeficiency Virus and Receiving Antiretroviral Therapy in the United States.
Autorzy :
Venkatesh KK; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Ohio State University, Columbus, Ohio, USA.
Morrison L; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Tuomala RE; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts, USA.
Stek A; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Read JS; Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California, USA.
Shapiro DE; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Livingston EG; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 15; Vol. 73 (6), pp. 969-978.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-HIV Agents*/adverse effects
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Pregnancy Complications, Infectious*/drug therapy
Pregnancy Complications, Infectious*/epidemiology
Premature Birth*
Female ; HIV ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical ; Pregnancy ; Pregnant Women ; United States/epidemiology ; Viral Load
Czasopismo naukowe
Tytuł :
Anonymous Linkage Between College Students and Human Immunodeficiency Virus (HIV) Facilities: Systematic Evaluation of Urine Self-Collection for HIV Testing Initiative in China.
Autorzy :
Lv Y; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Li G; School of Medicine and Vanke School of Public Health, Tsinghua University Beijing, China.; Tsinghua Clinical Research Institute, School of Medicine, Tsinghua University, Beijing, China.
Hu M; Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing, China.
Xu C; Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing, China.
Lu H; Beijing Center for Disease Prevention and Control, Beijing Center for Preventive Medical Research, Beijing, China.
Chen L; Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Sciences, Beijing, China.
Xing Y; Haidian District Center for Disease Prevention and Control, Beijing, China.
Liang S; Sichuan Center for Disease Control and Prevention, Chengdu, China.
Ma Y; Yunnan Center for Disease Control and Prevention, Kunming, China.
Liang S; Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning, China.
Zhuang M; Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.
Li Y; Heilongjiang Center for Disease Control and Prevention, Harbin, China.
Huang C; Beijing Center for Disease Prevention and Control, Beijing Center for Preventive Medical Research, Beijing, China.
Bai Y; Alibaba Group Holding Limited, Beijing, China.
Jiang Y; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhang L; School of Medicine and Vanke School of Public Health, Tsinghua University Beijing, China.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 07; Vol. 73 (5), pp. e1108-e1115.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections*/diagnosis
HIV Testing*
China ; HIV ; Homosexuality, Male ; Humans ; Male ; Students
Czasopismo naukowe
Tytuł :
[Dual therapies as a treatment of human immunodeficiency virus : the end of a paradigm ?]
Autorzy :
Plum PE; Service d'Infectiologie, Médecine interne générale, CHU Liège, Belgique.
Darcis G; Service d'Infectiologie, Médecine interne générale, CHU Liège, Belgique.
Moutschen M; Service d'Infectiologie, Médecine interne générale, CHU Liège, Belgique.
Pokaż więcej
Transliterated Title :
L’arrivée des bithérapies dans le traitement du virus de l’immunodéficience humaine : la fin d’un dogme?
Źródło :
Revue medicale de Liege [Rev Med Liege] 2021 Sep; Vol. 76 (9), pp. 677-682.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Drug Therapy, Combination ; HIV ; Humans
Czasopismo naukowe
Tytuł :
Necrotizing periodontal diseases in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: A review.
Autorzy :
Balaji TM; Department of Dentistry, Bharathirajaa Hospital, and Research Institute, Chennai, India.
Varadarajan S; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Sujatha G; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Muruganandhan J; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Shanmugapriya R; Department of Periodontology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Raj AT; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Patil S; Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Saudi Arabia. Electronic address: .
Fageeh HI; Department of Preventive Dental Science, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Fageeh HN; Department of Preventive Dental Science, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Malik NH; Womens Medical and Dental College, Abbottabad, Pakistan.
Awan KH; College of Dental Medicine, Roseman University of Health Sciences, Utah, United States. Electronic address: .
Pokaż więcej
Źródło :
Disease-a-month : DM [Dis Mon] 2021 Sep; Vol. 67 (9), pp. 101168. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiretroviral Therapy, Highly Active*
HIV Infections*/complications
HIV Infections*/drug therapy
Periodontal Diseases*/complications
Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/drug therapy ; Acquired Immunodeficiency Syndrome/virology ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; CD4 Lymphocyte Count ; HIV ; Humans ; Periodontium/drug effects
Czasopismo naukowe
Tytuł :
Long-term weight gain after initiating combination antiretroviral therapy in treatment-naïve Asian people living with human immunodeficiency virus.
Autorzy :
Ando N; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan; Joint Research Centre for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Nishijima T; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan; Bureau of International Health Cooperation, National Centre for Global Health and Medicine, Tokyo, Japan.
Mizushima D; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
Inaba Y; Biostatistics Section Department of Clinical Research Centre, Chiba University Hospital, Chiba, Japan.
Kawasaki Y; Biostatistics Section Department of Clinical Research Centre, Chiba University Hospital, Chiba, Japan.
Kikuchi Y; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan.
Oka S; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan; Joint Research Centre for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Gatanaga H; AIDS Clinical Centre, National Centre for Global Health and Medicine, Tokyo, Japan; Joint Research Centre for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2021 Sep; Vol. 110, pp. 21-28. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Anti-HIV Agents*/adverse effects
HIV Infections*/drug therapy
Adult ; HIV ; Humans ; Oxazines/therapeutic use ; Pyridones/therapeutic use ; Weight Gain
Czasopismo naukowe
Tytuł :
Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy.
Autorzy :
Varadarajan S; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Balaji TM; Department of Dentistry, Bharathirajaa Hospital, and Research Institute, Chennai, India.
Kumar S N; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Indu Bharkavi SK; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Thangavel G; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Raj AT; Department of Oral Pathology and Microbiology, Sri Venkateswara Dental College and Hospital, Chennai, India.
Patil S; Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan, Saudi Arabia. Electronic address: .
Al-Iryani GM; Faculty of Dentistry, Sana'a University, Yemen. Prince Mohammed Bin Nasser Hospital, Ministry of Health, Saudi Arabia.
Ali FM; Department of Oral and Maxillofacial Surgery, College of Dentistry, Jazan University, Jazan, Saudi Arabia.
Awan KH; College of Dental Medicine, Roseman University of Health Sciences, South Jordan, UT, United States. Electronic address: .
Pokaż więcej
Źródło :
Disease-a-month : DM [Dis Mon] 2021 Sep; Vol. 67 (9), pp. 101167. Date of Electronic Publication: 2021 Feb 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiretroviral Therapy, Highly Active*
HIV Infections*/complications
HIV Infections*/drug therapy
Mouth Diseases*/complications
AIDS-Related Opportunistic Infections ; Acquired Immunodeficiency Syndrome/complications ; Acquired Immunodeficiency Syndrome/drug therapy ; Acquired Immunodeficiency Syndrome/virology ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; CD4 Lymphocyte Count ; HIV ; Humans ; Mouth/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies